NO920338L - Tricyklisk pyridonderivat - Google Patents

Tricyklisk pyridonderivat

Info

Publication number
NO920338L
NO920338L NO92920338A NO920338A NO920338L NO 920338 L NO920338 L NO 920338L NO 92920338 A NO92920338 A NO 92920338A NO 920338 A NO920338 A NO 920338A NO 920338 L NO920338 L NO 920338L
Authority
NO
Norway
Prior art keywords
pyridone derivative
compound
formula
tricyclic pyridone
tricyclic
Prior art date
Application number
NO92920338A
Other languages
English (en)
Norwegian (no)
Other versions
NO920338D0 (no
Inventor
Richard Raimund Scherschlicht
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO920338D0 publication Critical patent/NO920338D0/no
Publication of NO920338L publication Critical patent/NO920338L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/15Suppositories

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92920338A 1991-01-25 1992-01-24 Tricyklisk pyridonderivat NO920338L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH22891 1991-01-25

Publications (2)

Publication Number Publication Date
NO920338D0 NO920338D0 (no) 1992-01-24
NO920338L true NO920338L (no) 1992-07-27

Family

ID=4182207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920338A NO920338L (no) 1991-01-25 1992-01-24 Tricyklisk pyridonderivat

Country Status (30)

Country Link
US (2) US5281711A (ru)
EP (1) EP0496274B1 (ru)
JP (1) JPH0739415B2 (ru)
KR (1) KR920014811A (ru)
AT (1) ATE140002T1 (ru)
AU (1) AU649302B2 (ru)
BG (1) BG61057B2 (ru)
BR (1) BR9200217A (ru)
CA (1) CA2058640A1 (ru)
CZ (1) CZ280258B6 (ru)
DE (1) DE59206676D1 (ru)
DK (1) DK0496274T3 (ru)
ES (1) ES2089252T3 (ru)
FI (1) FI920268A (ru)
GR (1) GR3021126T3 (ru)
HU (2) HU207072B (ru)
IE (1) IE920225A1 (ru)
IL (1) IL100702A (ru)
IS (1) IS3804A (ru)
LT (1) LT3473B (ru)
LV (1) LV10275B (ru)
MX (1) MX9200242A (ru)
MY (1) MY108199A (ru)
NO (1) NO920338L (ru)
NZ (1) NZ241341A (ru)
RU (1) RU2073678C1 (ru)
SI (1) SI9210067A (ru)
UY (1) UY23362A1 (ru)
YU (1) YU48221B (ru)
ZA (1) ZA92361B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법
US7277767B2 (en) 1999-12-10 2007-10-02 Srs Labs, Inc. System and method for enhanced streaming audio
US8445700B2 (en) 2008-11-24 2013-05-21 Council Of Scientific & Industrial Research Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines
US9258664B2 (en) 2013-05-23 2016-02-09 Comhear, Inc. Headphone audio enhancement system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191427B (en) * 1984-07-16 1987-02-27 Budapesti Mueszaki Egyetem,Hu Piezooptical effect reduced electrooptical light modulator
ZW17385A1 (en) * 1984-11-06 1986-02-19 Hoffmann La Roche Tricyclic pyridine derivatives
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
DK0496274T3 (da) 1996-09-23
KR920014811A (ko) 1992-08-25
JPH0739415B2 (ja) 1995-05-01
HUT60266A (en) 1992-08-28
EP0496274A1 (de) 1992-07-29
ES2089252T3 (es) 1996-10-01
HU9200128D0 (en) 1992-04-28
CZ280258B6 (cs) 1995-12-13
NO920338D0 (no) 1992-01-24
HU211259A9 (en) 1995-11-28
YU6792A (sh) 1994-11-15
LV10275A (lv) 1994-10-20
SI9210067A (en) 1995-02-28
BG61057B2 (bg) 1996-09-30
IS3804A (is) 1992-07-26
BR9200217A (pt) 1992-10-06
JPH04312585A (ja) 1992-11-04
IE920225A1 (en) 1992-07-29
IL100702A (en) 1995-08-31
HU207072B (en) 1993-03-01
YU48221B (sh) 1997-08-22
ZA92361B (en) 1992-09-30
LT3473B (en) 1995-10-25
NZ241341A (en) 1993-12-23
LTIP801A (en) 1995-02-27
EP0496274B1 (de) 1996-07-03
MY108199A (en) 1996-08-30
FI920268A0 (fi) 1992-01-22
ATE140002T1 (de) 1996-07-15
RU2073678C1 (ru) 1997-02-20
LV10275B (en) 1995-02-20
MX9200242A (es) 1992-07-01
AU1034092A (en) 1992-07-30
CS18292A3 (en) 1992-08-12
CA2058640A1 (en) 1992-07-26
IL100702A0 (en) 1992-09-06
US5326769A (en) 1994-07-05
UY23362A1 (es) 1992-07-21
GR3021126T3 (en) 1996-12-31
DE59206676D1 (de) 1996-08-08
AU649302B2 (en) 1994-05-19
FI920268A (fi) 1992-07-26
US5281711A (en) 1994-01-25

Similar Documents

Publication Publication Date Title
AU674477B2 (en) Heterocyclic-cyclic amine derivatives
BG102600A (en) Carbamoyloxy derivatives of mutilin and their use as bactericides
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
MY116124A (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
MY106259A (en) 2-aminopyrimidinone derivatives.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
ATE140002T1 (de) Tricyclisches pyridonderivat
AU686955B2 (en) Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives
NO914056L (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
BG97633A (en) Indenoindole compounds
YU12191A (sh) Kristalni hidrohlorid novog beta-laktamskog antibiotika i postupak za njegovo dobijanje
DK0488044T3 (da) En imidazobenzodiazepin til behandling af søvnforstyrrelser
ES2036502A6 (es) Mejoras en el objeto de la patente n{ 9003113 por procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiridina.
AU8377691A (en) Use of N-(1-hexahydroazepinylalkyl)acetamides for the treatment of cholinergic transmission disorders